Unfortunately the press doesn't do their homework.

Around 48,000 patients have taken Tysabri at some point after it was brought back to market. Out of these patients, 5 have been confirmed to have PML. The 3 other cases were in the registration trials (non-montherapy) out of about 3000 patients in the trials.